132 related articles for article (PubMed ID: 9017960)
1. The coagulofibrinolytic state of patients with primary varicose veins of the lower legs.
Ikeda M; Kambayashi J; Iwamoto S; Shinoki N; Nakamura T; Shibuya T; Kawasaki T; Monden M
Surg Today; 1996; 26(12):985-9. PubMed ID: 9017960
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic value of plasma thrombin-antithrombin III complex and D-dimer concentration in patients with varicose veins for exclusion of deep-vein thrombosis.
Kawasaki T; Shinoki N; Iwamoto S; Fujimura H; Yoshikawa N; Ohta Y; Ikeda M; Ariyoshi H; Shibuya T; Monden M
Thromb Res; 1998 Jul; 91(2):101-4. PubMed ID: 9722026
[TBL] [Abstract][Full Text] [Related]
3. Superficial thrombophlebitis of the lower limbs in patients with varicose veins.
Unno N; Mitsuoka H; Uchiyama T; Yamamoto N; Saito T; Ishimaru K; Kaneko H; Nakamura S
Surg Today; 2002; 32(5):397-401. PubMed ID: 12061687
[TBL] [Abstract][Full Text] [Related]
4. Treatment of varicose veins: an assessment of intraoperative and postoperative compression sclerotherapy.
Iwamoto S; Ikeda M; Kawasaki T; Monden M
Ann Vasc Surg; 2003 May; 17(3):290-5. PubMed ID: 12704548
[TBL] [Abstract][Full Text] [Related]
5. Sclerotherapy for varicose veins of the lower legs in patients with dysplasminogenemia.
Ikeda M; Kawasaki T; Kambayashi J; Iwamoto S; Shinoki N; Nakamura T; Shibuya T; Monden M
Surg Today; 1997; 27(8):714-8. PubMed ID: 9306585
[TBL] [Abstract][Full Text] [Related]
6. Hemostasis activation during sclerotherapy of lower extremity varices.
Ikeda M; Kambayashi J; Iwamoto S; Shinoki N; Nakamura T; Okahara K; Fujitani K; Shibuya T; Kawasaki T; Monden M
Thromb Res; 1996 Apr; 82(1):87-95. PubMed ID: 8731513
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic significance of thrombin-antithrombin III complex (TAT) and D-dimer in patients with deep venous thrombosis.
Sassa H; Sone T; Tsuboi H; Kondo J; Yabashi T
Jpn Circ J; 1996 Apr; 60(4):201-6. PubMed ID: 8726168
[TBL] [Abstract][Full Text] [Related]
8. Influence of long term oral anticoagulants upon prothrombin fragment 1 + 2, thrombin-antithrombin III complex and D-Dimer levels in patients affected by proximal deep vein thrombosis.
Elias A; Bonfils S; Daoud-Elias M; Gauthier B; Sié P; Boccalon H; Boneu B
Thromb Haemost; 1993 Apr; 69(4):302-5. PubMed ID: 8497840
[TBL] [Abstract][Full Text] [Related]
9. The possible risk of lower-limb sclerotherapy causing an extended hypercoagulable state.
Ariyoshi H; Kambayashi J; Tominaga S; Hatanaka T
Surg Today; 1996; 26(5):323-7. PubMed ID: 8726616
[TBL] [Abstract][Full Text] [Related]
10. d-Dimer Levels are Significantly Increased in Blood Taken From Varicose Veins Compared With Antecubital Blood From the Same Patient.
Lattimer CR; Kalodiki E; Geroulakos G; Syed D; Hoppensteadt D; Fareed J
Angiology; 2015 Oct; 66(9):882-8. PubMed ID: 25561693
[TBL] [Abstract][Full Text] [Related]
11. Prothrombin fragment 1 + 2, thrombin-antithrombin III complexes and D-dimers in acute deep vein thrombosis: effects of heparin treatment.
Estivals M; Pelzer H; Sie P; Pichon J; Boccalon H; Boneu B
Br J Haematol; 1991 Jul; 78(3):421-4. PubMed ID: 1873225
[TBL] [Abstract][Full Text] [Related]
12. High F1.2 fragment of prothrombin, thrombin-antithrombin III complex (TAT) and soluble fibrin plasma levels demonstrate hypercoagulability induced during loco-regional thrombolytic therapy with rt-PA.
Garcia-Avello A; Garcia-Frade LJ; Gandarias C; Ocaña J; Cancelas JA; Lasso M
Thromb Res; 1994 Jan; 73(2):109-15. PubMed ID: 8171409
[TBL] [Abstract][Full Text] [Related]
13. Effects of recombinant hirudin on D dimer levels before and after experimental venous thrombosis.
Monreal M; Angles AM; Monreal L; Roncales J; Monasterio J
Haemostasis; 1994; 24(6):338-43. PubMed ID: 7843645
[TBL] [Abstract][Full Text] [Related]
14. Hemostasis activation during esophageal variceal sclerotherapy with thrombin in cirrhotics.
Fujii Y; Sugawa C; Ozawa T; Nakumura R; Brown-Castillo J; Mammen EF
Am Surg; 1991 Apr; 57(4):222-5. PubMed ID: 1711300
[TBL] [Abstract][Full Text] [Related]
15. Plasma levels of D-dimer: a crosslinked fibrin-degradation product in female breast cancer.
Mitter CG; Zielinski CC
J Cancer Res Clin Oncol; 1991; 117(3):259-62. PubMed ID: 2033094
[TBL] [Abstract][Full Text] [Related]
16. Is quantitative determination of fibrin(ogen) degradation products and thrombin-antithrombin III complexes useful to diagnose deep venous thrombosis in outpatients?
van Bergen PF; Knot EA; Jonker JJ; de Boer AC; de Maat MP
Thromb Haemost; 1989 Dec; 62(4):1043-5. PubMed ID: 2694421
[TBL] [Abstract][Full Text] [Related]
17. D-dimer and thrombin-antithrombin III complex levels uncorrelated with phlebographic findings in 11 total knee replacement patients.
De Prost D; Ollivier V; Vie P; Benacerraf R; Duparc J; Khoury A
Ann Biol Clin (Paris); 1990; 48(4):235-8. PubMed ID: 2193559
[TBL] [Abstract][Full Text] [Related]
18. Prethrombotic state due to hypercoagulability in patients with permanent transvenous pacemakers.
Ito T; Tanouchi J; Kato J; Nishino M; Iwai K; Tanahashi H; Hori M; Yamada Y; Kamada T
Angiology; 1997 Oct; 48(10):901-6. PubMed ID: 9342969
[TBL] [Abstract][Full Text] [Related]
19. Clinical utility of prothrombin fragment 1+2, thrombin antithrombin III complexes and D-dimer measurements in the diagnosis of deep vein thrombosis following total hip replacement.
Cofrancesco E; Cortellaro M; Corradi A; Ravasi F; Bertocchi F
Thromb Haemost; 1998 Mar; 79(3):509-10. PubMed ID: 9531030
[TBL] [Abstract][Full Text] [Related]
20. Increase in the D-dimer levels during treatment in patients with acute myelogenous leukemia.
Velasco F; Torres A; Rojas R; Alvarez MA; Gomez P; Castillo D
Haemostasis; 1992; 22(3):117-23. PubMed ID: 1427455
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
